Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Raman-active reagents and the use thereof

a technology of raman and active reagents, applied in the field of ramanactive reagents, can solve the problems of limited reliable individual and quantitative detection of multiple analytes in a single sample, limited use of fluorescence spectroscopy, and insufficient sensitivity of conventional raman spectroscopy for use as immunoassay readout methods, etc., to achieve the effect of reducing labor costs, signal stability, and sensitivity

Inactive Publication Date: 2011-03-24
IOWA STATE UNIV RES FOUND
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0017]The Raman-active reagents may be manufactured in the lab or provided to the user in the form of a kit. The kit may include a previously prepared Raman-active reagent, or the ingredients for manufacturing the Raman-active reagents in the lab. The kit may also include ingredients that minimize nonspecific binding and ingredients that stabilize the reagent to extend its shelf life. In addition, the kit may include a capture substrate covered with binding molecules to immobilize analytes for subsequent detection with the Raman active reagent. For the simultaneous detection of multiple analytes, the kit may also include unreactive spacer molecules, such as molecules terminated with ethylene glycol units, for interspersing amongst the binding molecules so as to minimize steric interferences as well as to resist nonspecific adsorption.
[0020]The Raman-active reagents of the present invention serve as an alternative to fluorescence-labeled reagents, with advantages in detection including signal stability, sensitivity, and the ability to simultaneously detect several analytes in a single test sample. Because of the ability to simultaneously detect several analytes in a single test sample, faster analysis speeds and reduced labor costs may be obtained.

Problems solved by technology

Although fluorescence spectroscopy has seen substantial use in scientific research and clinical diagnostics, there are disadvantages in using fluorescence spectroscopy.
If a single light source is used, there will often exist a spectral overlap between the emission of the different fluorescent molecules such that reliable individual and quantitative detection of multiple analytes in a single sample is limited.
Conventional Raman spectroscopy usually lacks sufficient sensitivity for use as a readout method for immunoassays.
Raman spectroscopy is also unsuccessful for fluorescent materials due to the broad fluorescence emission bands tend to swamp the weaker Raman bands.
A major barrier that prohibits using SERS for the direct detection of biological samples is that the surface enhancement effect diminishes rapidly with increasing distance from the metallic surfaces.
In addition, although Raman spectra of biomolecules can be obtained on silver surfaces when coupling SERS and resonance enhanced scattering, the spectra are usually lacking of sufficient chemical content and / or signal amplitude to be used for immunoassay purposes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Raman-active reagents and the use thereof
  • Raman-active reagents and the use thereof
  • Raman-active reagents and the use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Raman-Active Reporter Molecule 4,4′-dithiobis(succinimidylbenzoate)

[0062]The Raman-active reporter molecule 4,4′-dithiobis(succinimidylbenzoate) (DSB) was synthesized following a procedure similar to that used for preparing dithiobis(succinimidylundecanoate) as described in Wagner et al., Biophys. J. 1996, 70, 2052, 15 which is incorporated herein by reference. Briefly, 0.50 g of the reporter molecule dithiobisbenzonic acid (DBA) (1.6 mmol) (Toronto Research Chemicals, Inc), 0.67 g of 1,3dicyclohexylcarbodiimide (DCCD) (3.2 mmol) (obtained from Aldrich), 0.37 g of Nhydroxysuccinimide (NHS) (3.2 mmol) (obtained from Aldrich), and 60 mL of tetrahydrofuran were added to a 100 mL round-bottom flask equipped with a magnetic stir bar and drying tube. The reaction mixture was stirred at room temperature for three days. The solution was then filtered and the solvent was removed under reduced pressure to give an orange residue. The crude product was dissolved in hot acetone and ...

example 2

“Preparation of Raman-Active Reagents Using Co-Immobilization

[0063]Raman-active immunogold colloidal reagents were prepared using the co-immobilization approach depicted in FIG. 1(a). First, 25 μL of ethanolic Raman reporter solution (0.5 mM DBA) was added to 10 mL of a suspension of uncoated gold colloids (˜30 nm diameter, 2×1011 particles / mL) (Ted Pella, Inc.). The mixture was allowed to react for 5 hours at room temperature. During this step, the reporter molecules bound via self-assembly onto the colloid surface through the formation of sulfur-gold linkages. We note that this amount of reporter, based on an estimation of the colloidal surface area, will only partially cover the colloid, leaving portions of the uncoated colloidal surface available for protein immobilization. After separating the reporter-labeled colloids from solution by centrifugation at 14,000 g for 4 minutes, the loosely packed, red-colored sediment was resuspended in 10 mL of borate buffer (2 mM, pH 9).

[0064]...

example 3

Preparation of Raman-Active Reagents Using a Covalent Linking

[0065]Raman-active immunogold colloidal reagents were prepared using the covalent linking approach depicted in FIG. 1(b). The DSB molecules were used as both Raman reporters and antibody linkers. The succinimide ester group of the DSB molecule can readily react with the primary amine group of an amino acid, such as the lysine, present in antibodies such as IgG to form a covalent bond. As shown in Scheme 2, the preparation of the covalently-linked colloidal reagent follows a process very similar to that used for the co-immobilized reagents. However, with the covalent linking approach, the antibodies indirectly attached to the colloid through the reporter molecules rather than directly adsorbed onto the colloidal surface. Briefly, 25 μL of a reporter-linker solution (5 mM DSB in CHCl3) was added to 10 mL of bare gold suspension (30 nm) under vigorous agitation. The molecules self-assemble onto the colloid surface, with their...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
angleaaaaaaaaaa
Login to View More

Abstract

The present invention provides a new class of Raman-active reagents for use in biological and other applications, as well as methods and kits for their use and manufacture. Each reagent includes a Raman-active reporter molecule, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering (SERS). The Raman-active reporter molecule and the binding molecule are affixed to the particle to give both a strong SERS signal and to provide biological functionality, i.e. antigen or drug recognition. The Raman-active reagents can function as an alternative to fluorescence-labeled reagents, with advantages in detection including signal stability, sensitivity, and the ability to simultaneously detect several biological materials. The Raman-active reagents also have a wide range of applications, especially in clinical fields (e.g., immunoassays, imaging, and drug screening).

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This is a Divisional Application of U.S. Ser. No. 09 / 961,628 filed Sep. 24, 2001, which claims the benefit of U.S. Provisional Application 60 / 234,608, filed Sep. 22, 2000, herein incorporated by reference in their entirety.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]None.BACKGROUND OF THE INVENTION[0003]Many assays exist for detecting and measuring analytes of small quantity in the presence of a large volume of other substances. Such assays typically make use of the high binding affinity between the analyte (the substance to be detected or measured) and a second molecule having a high degree of specificity for binding to that analyte. These assays are often referred to as ligand-binding assays.[0004]One of the most common ligand-binding assays are immunoassays. Immunoassays typically employ an antigen and an antibody which specifically binds to the antigen to form an antibody / antigen complex. In order to measure t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/53G01N21/00
CPCG01N21/658G01N33/54373Y10T436/24G01N33/587G01N33/553
Inventor PORTER, MARC D.NI, JINGLIPERT, ROBERT J.DAWSON, G. BRENT
Owner IOWA STATE UNIV RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com